What is the official website of Expert Perspectives by Engage Health Media ?

The official website of Expert Perspectives by Engage Health Media is http://expertperspectives.com/endocrinology/diabetes-mellitus/.

What is Expert Perspectives by Engage Health Media's cybersecurity risk score?

Expert Perspectives by Engage Health Media has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Expert Perspectives by Engage Health Media experienced?

According to Rankiteo, Expert Perspectives by Engage Health Media currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Expert Perspectives by Engage Health Media been affected by any supply chain cyber incidents ?

According to Rankiteo, Expert Perspectives by Engage Health Media has been affected by a supply chain cyber incident involving Snowflake, with the incident ID ATT1764820523.

Does Expert Perspectives by Engage Health Media have SOC 2 Type 1 certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not certified under SOC 2 Type 1.

Does Expert Perspectives by Engage Health Media have SOC 2 Type 2 certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media does not hold a SOC 2 Type 2 certification.

Does Expert Perspectives by Engage Health Media comply with GDPR ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not listed as GDPR compliant.

Does Expert Perspectives by Engage Health Media have PCI DSS certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media does not currently maintain PCI DSS compliance.

Does Expert Perspectives by Engage Health Media comply with HIPAA ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not compliant with HIPAA regulations.

Does Expert Perspectives by Engage Health Media have ISO 27001 certification ?

According to Rankiteo,Expert Perspectives by Engage Health Media is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Expert Perspectives by Engage Health Media operate in ?

Expert Perspectives by Engage Health Media operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media employs approximately 0 people worldwide.

Does Expert Perspectives by Engage Health Media own any subsidiaries ?

Expert Perspectives by Engage Health Media presently has no subsidiaries across any sectors.

How many LinkedIn followers does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media's official LinkedIn profile has approximately 40 followers.

What is the NAICS classification code for Expert Perspectives by Engage Health Media ?

Expert Perspectives by Engage Health Media is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Expert Perspectives by Engage Health Media have a Crunchbase profile ?

No, Expert Perspectives by Engage Health Media does not have a profile on Crunchbase.

Does Expert Perspectives by Engage Health Media have a LinkedIn profile ?

Yes, Expert Perspectives by Engage Health Media maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/expert-perspectives.

How many cybersecurity incidents has Expert Perspectives by Engage Health Media experienced ?

As of July 27, 2026, Rankiteo reports that Expert Perspectives by Engage Health Media has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media has an estimated 5,709 peer or competitor companies worldwide.

What types of cybersecurity incidents has Expert Perspectives by Engage Health Media faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

EPEHM

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Expert Perspectives by Engage Health Media Vendor Cyber Rating & Cyber Score

expertperspectives.com

Add Your Compliance Badge

A customized publication featuring highly prominent thought leaders providing their expert opinions, insights, and commentary on the leading topics and issues in specific disease state medicine.

EPEHM A.I CyberSecurity Scoring

Scoring History

EPEHM

Expert Perspectives by Engage Health Media CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Omnicom

Breach

1/2024

Snowflake

ATT1764820523

Loading…

A.I.

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incident History - EPEHM (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Pharmaceutical Manufacturing

Website: http://expertperspectives.com/endocrinology/diabetes-mellitus/

Company Size: 0

OmnicomAdvertising Services

DDB Mudra GroupAdvertising Services

Wolff OlinsDesign Services

AlmapBBDOAdvertising Services

Zimmerman AdvertisingAdvertising Services

IMPACT BBDOAdvertising Services

AMV BBDOAdvertising Services

TMA (The Marketing Arm)Advertising Services

FanscapeAdvertising Services

Omnicom Media Group Asia PacificAdvertising Services

sparks & honeyBusiness Consulting and Services

Patients & PurposeAdvertising Services

cdmAdvertising Services

Javelin AgencyAdvertising Services

Omnicom Media Group SpainAdvertising Services

BBDO & Proximity EspañaAdvertising Services

Somos #WEObservatorioAdvertising Services

HaygarthAdvertising Services

Doremus+CoAdvertising Services

B2BSideAdvertising Services

OmnicomMediaGroup USAAdvertising Services

Rabin MartinBusiness Consulting and Services

Private Sector Roundtable on Global Health Security (PSRT)International Affairs

BBDO GuerreroAdvertising Services

Beanstalk - Brand Extension Licensing AgencyMarketing Services

Tinderbox - Digital Brand LicensingAdvertising Services

Beanstalk América LatinaServicios de publicidad

Entrée HealthAdvertising Services

Omnicom PR GroupPublic Relations and Communications Services

Adelphi ValuesPharmaceutical Manufacturing

Proximity WorldwideAdvertising Services

KERNAdvertising Services

Resolution DigitalAdvertising Services

BBDO EcuadorAdvertising Services

Graviti BBDOAdvertising Services

SSCG Media GroupAdvertising Services

BBDO NordicsAdvertising Services

ConePublic Relations and Communications Services

NOVUS Media LLCAdvertising Services

H&S CommunicationsPublic Relations and Communications Services

OMD ArgentinaAdvertising Services

Serino CoyneAdvertising Services

Archbow ConsultingPharmaceutical Manufacturing

Ketchum BrazilPublic Relations and Communications Services

AlconeAdvertising Services

MTS | Marketing Technology SolutionsAdvertising Services

PHD, Inc.Industrial Automation

PHD, Inc. | Europe Herstellung von Automatisierungsanlagen

PHD, Inc. | China工业自动化

InteroneAdvertising Services

ColangeloAdvertising Services

The Scienomics GroupAdvertising Services

Omnicom CommerceAdvertising Services

Proximedia BelgiumInternet Publishing

Casers GroupAdvertising Services

Omnicom Media Group, CzechAdvertising Services

OMG (Omni Marketing Global)Advertising Services

ActMedia (OMG)Advertising Services

DemoPower (OMG)Advertising Services

CPC (OMG)Advertising Services

Graffiti BBDOAdvertising Services

Fishburn HedgesPublic Relations and Communications Services

Omnicom PR Group NLPublic Relations and Communications Services

Brandzeichen Markenberatung und Kommunikation GmbHPublic Relations and Communications Services

Child and Youth Care Association of AlbertaCivic and Social Organizations

Davie Brown EntertainmentEntertainment Providers

U30 GroupMarket Research

DDB Frankfurt GmbHAdvertising Services

Omnicom Health Group: Snow CompaniesAdvertising Services

OMD Optimum Media UkraineAdvertising Services

BBDO Proximity DuesseldorfAdvertising Services

BAREFOOTAdvertising Services

TRANSACT NorwayAdvertising Services

Tribal Worldwide AthensAdvertising Services

Sterling International Consulting GroupIT Services and IT Consulting

OPERA / Omnicom Media GroupAdvertising Services

K Comms GmbH (Swiss Partner of KetchumPleon)Public Relations and Communications Services

Omnicom Media Group FranceAdvertising Services

TPNAdvertising Services

The Zimmerman AgencyMarketing Services

BBDO San FranciscoAdvertising Services

Agency 720Advertising Services

BioPharm CommunicationsAdvertising Services

Loading…

Expert Perspectives by Engage Health Media Similar Companies

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Loading…

NEWS

Expert Perspectives by Engage Health Media CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

It establishes liability for use of AI that violates consumer protection laws if not properly disclosed and requires disclosure when an ...

Read Article

What the HIPAA rulemaking notice means for you

The notice of proposed rulemaking from HHS in December 2024 that was designed to strengthen cybersecurity requirements.

Read Article

Prioritising eHealth cybersecurity against emerging challenges

The rising digitalisation and interconnectedness in healthcare has significantly increased the sector's exposure to cyber threats and raised ...

Read Article

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Medical Channel Asia's Q1 2025 data highlights the scale of public demand for trusted health information, with close to 200,000 page views on ...

Read Article

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

ChatGPT can help people be more creative and productive and improve organisational knowledge management. But it amplifies many AI challenges that organisations ...

Read Article

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

In 2025 the new normal will imply a society more sharply divided between those who have access and those who don't. Fernando Barrio, a lecturer ...

Read Article

Countering Disinformation Effectively: An Evidence-Based Policy Guide

A high-level, evidence-informed guide to some of the major proposals for how democratic governments, platforms, and others can counter ...

Read Article

How wellness-as-a-service can drive growth for life and health insurers

Discover how wellness-as-a-service can drive growth for life and health insurers by integrating physical & financial health and leveraging ...

Read Article

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

“Harmful or menacing changes in digital technology and humans' use of digital systems happen because we have not sufficiently prepared ourselves ...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-57990

SUMMARY

Files or directories accessible to external parties in Microsoft Edge (Chromium-based) allows an unauthorized attacker to disclose information over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57990

CVE-2026-57989

SUMMARY

Origin validation error in Microsoft Edge (Chromium-based) allows an unauthorized attacker to disclose information over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57989

CVE-2026-57978

SUMMARY

Origin validation error in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57978

CVE-2026-17497

SUMMARY

NoteGen before 0.32.0 grants the Tauri shell plugin shell:allow-execute capability for bash, python, and python3 with arbitrary arguments in the default desktop capabilities. JavaScript running in the application webview can therefore invoke plugin:shell|execute to run attacker-controlled operating system commands with the privileges of the NoteGen process. In combination with script execution in the webview (for example via chat XSS), this enables full remote code execution on the user's machine.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 8.3)

cvss3

Base Score: 8.3

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:H

Impact Score

Exploitability

1.6

REFERENCES

CVE-2026-17496

SUMMARY

NoteGen before 0.32.0 renders AI chat responses with markdown-it configured with html:true and injects the result into the DOM via dangerouslySetInnerHTML in chat-preview, without HTML sanitization and with CSP set to null. Attacker-controlled content that reaches the model prompt (for example a malicious skill REFERENCE.md that instructs the model to emit HTML) can cause the model response to include executable markup such as an img onerror handler. When the user views the chat response, that markup runs as JavaScript in the privileged Tauri webview, enabling arbitrary script execution in the application context (cross-site scripting).

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Expert Perspectives by Engage Health Media Vendor Cyber Rating & Cyber Score

EPEHM A.I CyberSecurity Scoring

Expert Perspectives by Engage Health Media CyberSecurity News & History

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - EPEHM (X = Date, Y = Severity)

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Expert Perspectives by Engage Health Media Similar Companies

Viatris

Servier

Glenmark Pharmaceuticals

UCB

Merck

Alembic Pharmaceuticals Limited

Cipla

Hikma Pharmaceuticals

Zoetis

Expert Perspectives by Engage Health Media CyberSecurity News

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

What the HIPAA rulemaking notice means for you

Prioritising eHealth cybersecurity against emerging challenges

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

Countering Disinformation Effectively: An Evidence-Based Policy Guide

How wellness-​as-a-service can drive growth for life and health insurers

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Expert Perspectives by Engage Health Media CyberSecurity News & History

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - EPEHM (X = Date, Y = Severity)

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Expert Perspectives by Engage Health Media Similar Companies

Viatris

Servier

Glenmark Pharmaceuticals

UCB

Merck

Alembic Pharmaceuticals Limited

Cipla

Hikma Pharmaceuticals

Zoetis

Expert Perspectives by Engage Health Media CyberSecurity News

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

What the HIPAA rulemaking notice means for you

Prioritising eHealth cybersecurity against emerging challenges

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

Countering Disinformation Effectively: An Evidence-Based Policy Guide

How wellness-​as-a-service can drive growth for life and health insurers

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

How wellness-as-a-service can drive growth for life and health insurers

How wellness-as-a-service can drive growth for life and health insurers